yohimbine and jp-1302
yohimbine has been researched along with jp-1302 in 4 studies
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Imaki, J; Mae, Y; Ohno, Y; Shimizu, S | 1 |
| Afonso, J; Moura, E; Pinto, CE; Serrão, MP; Vieira-Coelho, MA | 1 |
| Miura, T; Nishinaka, T; Shimokawa, T; Takama, M; Tanba, T; Terada, T; Tojo, A; Tsutsui, H; Yamagata, M; Yoshida, S; Yukimura, T | 1 |
| Miura, T; Nishinaka, T; Shimokawa, T; Takama, M; Terada, T; Tsutsui, H; Yamagata, M; Yukimura, T | 1 |
Other Studies
4 other study(ies) available for yohimbine and jp-1302
| Article | Year |
|---|---|
Therapeutic potential of alpha2 adrenoceptor antagonism for antipsychotic-induced extrapyramidal motor disorders.
Topics: Acridines; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Antipsychotic Agents; Catalepsy; Dose-Response Relationship, Drug; Haloperidol; Hypokinesia; Imidazoles; Isoindoles; Male; Mice; Motor Activity; Piperazines; Yohimbine | 2009 |
Catecholamine synthesis and metabolism in the central nervous system of mice lacking alpha-adrenoceptor subtypes.
Topics: Acridines; Adrenergic alpha-2 Receptor Antagonists; Animals; Aromatic-L-Amino-Acid Decarboxylases; Biological Transport; Brain; Catechol O-Methyltransferase; Catecholamines; Cell Line, Tumor; Dopamine beta-Hydroxylase; Humans; Levodopa; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Monoamine Oxidase; Piperazines; Receptors, Adrenergic, alpha-2; Tyrosine 3-Monooxygenase; Yohimbine | 2009 |
Renoprotective effect of yohimbine on ischaemia/reperfusion-induced acute kidney injury through α2C-adrenoceptors in rats.
Topics: Acridines; Acute Kidney Injury; Adrenergic alpha-2 Receptor Antagonists; Animals; Chemokine CCL2; Cytoprotection; Gene Expression Regulation; Kidney; Male; Norepinephrine; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Reperfusion Injury; Tumor Necrosis Factor-alpha; Yohimbine | 2016 |
Inhibition of α2C-adrenoceptors ameliorates cisplatin-induced acute renal failure in rats.
Topics: Acridines; Acute Kidney Injury; Adrenergic alpha-2 Receptor Antagonists; Animals; Apoptosis; Chemokine CCL2; Cisplatin; Disease Models, Animal; Injections, Intraperitoneal; Kidney; Male; Norepinephrine; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Tumor Necrosis Factor-alpha; Yohimbine | 2018 |